Zvibvutiro zveRetatrutide: Zvidzidzo Zvekurapa Zvinotiudza Sei Kusvika Zvino

Zvibvutiro zvakajairika zveRetatrutide zvinokonzeresa matambudziko edumbu sekusevha, manyoka, kurutsa, uye kuvimbirwa. Izvi zvakafanana nezvinowanikwa nevanhu vane mamwe madhagi eGLP-1 sesemaglutide ne tirzepatide. Zvinowanzoonekwa pakutanga kwekurapa, kunyanya panguva yekuwedzera dosi, uye vanhu vazhinji vanowana zvichiderera kana muviri wacho uchigadzirisika.

Retatrutide ichiri mushonga uri pasi pekuedzwa. Hatiisati yapihwa mvumo neFDA uye parizvino iri muChikamu chechitatu chedzidzo dzekurapa. Saka zvose zvatinoziva nezvezvibvutiro zvawo zvinobva padata redzidzo. Asi pane huwandu hwe data hwekuongorora, kusanganisira zvabuda muTRIUMPH-4 Phase 3 trial ichangoburwa.

Ndezvipi Zvibvutiro Zvakajairika Kwazvo?

Mhuru yemudumbu ndiyo inonyanya kutambudzika, kana tichitarisa pakutanga. Izvi zvine musoro nekuti Retatrutide inoshanda nekumisikidza ma hormone receptors matatu (GLP-1, GIP, uye glucagon) anokanganisa kunzara, kufamba kwemudumbu, uye kuti dumbu rinoburitsa sei zvirimo.

MuTRIUMPH-4 Phase 3 trial, yakayesa maviri akakwirira kwazvo doses (9 mg ne 12 mg) muvanhu vakuru 445, zvibvutiro zvakanyanya kunyorwa pa 12 mg dose zvichienzaniswa neplacebo zvaive:

• Kusevha (43.2% vs 10.7% neplacebo)
• Manyoka (33.1% vs 13.4% neplacebo)
• Kuvimbirwa (25.0% vs 8.7% neplacebo)
• Kurutsa (20.9% vs 0.0% neplacebo)
• Kuderera kwechido chekudya (18.2% vs 9.4% neplacebo)

Iyo 9 mg dose yakaratidza mwero wakaderera zvishoma pamwe chete. Nhamba idzi dzakakwirira pane izvo zvaunowanzoona ne semaglutide kana tirzepatide, izvo zvine musoro nekuda kwekuti retatrutide isimba re triple-action drug. Asi maitiro acho akafanana. Zvibvutiro izvi zvakafanana neizvo zvinouya nemishonga yese muchikamu ichi.

Chinhu chakakosha kuziva ndechekuti zvikamu zvakawanda zvezvibvutiro izvi zvakaverengwa semidiki kusvika yepakati. Zvinonyanya kuonekwa mumavhiki ekutanga ekurapa uye panguva dzekuwedzera dosi, zvozo zvishoma nezvishoma zvichifambira mberi sezvo vanopa rubatsiro vaive pamwero wakagadzikana.

[IMG:https://assets.getbeyondhealth.com/health-lib/blogs/manual_upload_20260216024926_retatrutide-side-eff.png]

Retatrutide Inokanganisa Sei Kukurumidza Kwemoyo?

Ichi chinhu chakanga chiri chiongororwa ne vazvidzidzi. Mudzidzo dzeChikamu chechipiri, vamwe vanopa rubatsiro vakanga vari padosi akakwirira vakaona kuwedzera kudiki mukukurumidza kwemoyo pavanenge vasina kuita basa, avhareji yekukwira kwemawindo anosvika 5 kusvika 7 paminiti. Izvi zvakawedzera zvakanyanya pachikwata chevhiki rechi 24 ndokuzodzikira zvishoma nezvishoma kusvika mavhiki 36 kusvika 48.

Nhamba shoma yevatambi vakaonawo zvimwe zvishoma zvekuti moyo uridza sei. Nekudaro, hapana kuwedzera kwemazvombo zvemoyo kana zviitiko zvakakomba zvemoyo zvakambonzi zvine chekuita neRetatrutide mudzidzo ipi zvayo kusvika zvino. Muchokwadi, vatambi vacho vakawana kuvandudzika kwekumanikidzwa kweropa, cholesterol, nezvimwe zvimiro zve moyo. Mudzidzo yeTRIUMPH-4, iyo 12 mg dose yakadzikisa systolic blood pressure avhareji ye 14 mmHg.

Saka kunyangwe kuwedzera kudiki kwekukurumidza kwemoyo kuchikosha kuongorora, mamiriro ese emoyo anooneka achifadza zvichienderana nezvatinoziva nhasi.

Chii Chinonzi Dysesthesia Signal?

Uyu ndiwo mushumo mutsva wakabuda muTRIUMPH-4 Phase 3 results. Dysesthesia inonzwa isinganzwisisike kana isingafadzi paganda, dzimwe nguva inotsanangurwa sekutsinzinya, kuoma, kana kunzwa kwokupisa. Yakashumwa mu8.8% yevatambi padosi re 9 mg ne 20.9% padosi re 12 mg, ichienzaniswa ne 0.7% chete neplacebo.

Ichi chipiro hachina kuonekwa mudzidzo dzeChikamu chechipiri dzekutanga, saka chinhu chitsva chiri kuchiongororwa nevakundurudzi nevaongorori. Eli Lilly yakatsanangura zvakaitika sezvishoma, uye zvakashaya zvichitaurwa nevanhu kuti vatore kurapwa. Asi nezvinopfuura zvitanhatu zveChikamu chechitatu zvinotarisirwa muna 2026, ichi chichatariswa zvakanyanya kuti chionzwe kuti chakajairika sei uye kuti chinogadzirisika here nekufamba kwenguva.

Pane Zvibvutiro Zvakakomba Here?

Zviitiko zvekukomba nezvezvibvutiro zvine chekuita neRetatrutide zvakanga zvishoma mudzidzo kusvika zvino. Asi dzimwe nzira dzinogona kuitika dziri pamaonero nekuti dzakaonekwa nedzimwe mishonga yerudzi rweGLP-1.

Hezvino zviri kuongorora neveongorori:

• Pancreatitis (kuvhuvhama kwe pancreas) kwakaverengerwa kashoma nemishonga yeGLP-1 semugadziriro. Hapana zvakaonekwa zvine chokwadi chakabatanidzwa neRetatrutide, asi chinoramba chiri chinhu chinotarisa nacho vanachiremba. Zviratidzo zeyambiro zvinosanganisira kurwadziwa kusingaperi kwepamuviri kunogona kupinda kumusana.
• Matambudziko ehombodo, kusanganisira dombo rehombodo, akabatana nekurasikirwa kwekurema nekukurumidza uye nemimwe mishonga inobva ku-incretin. Dzidzo dziri kuongorora izvi neRetatrutide zvakare.
• Hypoglycemia (kuderera kweropa kune njodzi) hakuna kuva dambudziko rakakura mudzidzo. Hapana zvakaonekwa zvakakomba zvehypoglycemia, izvo zvinovimbisa.
• Kufambiswa kwemuviri kwechiropa neitsvo kwakaongororwa mudzidzo dzese, uye hapana zvakaratidza njodzi zvakadzama zvakazobuda munzvimbo idzi.

Zvakakosha kunotaura kuti hapana kufa kwakabatanidzwa neRetatrutide mune chero data redzidzo yekurapa yakabudiswa kusvika nhasi.

Vanhu Vangani Vakaramba Kurapwa Nekuda Kvezvibvutiro?

Mudzidzo yeTRIUMPH-4, mwero wekurambwa nekuda kwezviito zvakaipa waive 12.2% padosi re 9 mg ne 18.2% padosi re 12 mg, ichienzaniswa ne 4% neplacebo. Dzimwe dzekudzimwa idzi dzaive nekuda kweizvo Lilly yakatsanangura se "kurasikirwa kwekurema kwakanyanya," kwete nekuda kwekunzwa kusagadzikana.

Vazvidzidzi pavakaongorora chete vatambi vane BMI ye 35 kana yakakwirira pakutanga (zvinoreva kuti avo vane kufutisa kukuru), mwero wekurambwa wakadzikira kusvika 8.8% ne 12.1% pamadosi maviri. Izvi zvinoratidza kuti vanhu vane huremu hwekutanga hwakakwirira vangave vanotsungirira mushonga zviri nani, zvingave nekuti mwero wekurasikirwa kwekurema unooneka usina kunyanyisa kwavari.

[IMG:https://assets.getbeyondhealth.com/health-lib/blogs/manual_upload_20260216024317_retatrutide-side.png]

Nei Kuderera Kwemadose Kwakakosha?

Dzidzo dzeRetatrutide dzinotevedzera nzira yekudzikisira dosi zvishoma kune chimwe chikonzero. Vatori venhumbi vanotanga nedosi shoma ye 2 mg uye vanowedzera vhiki ina dzese kusvikira vasvika kadosi yavo. Iyi nzira yekukwira zvishoma inopa muviri wako nguva yekugadzirisa padanho rega rega vasati vaenda kune rinotevera.

Iyi nzira ndiyo nzira inonyatso shanda kudzikisa zvibvutiro. Kutanga wakatsika pamwero wakakwirira zvaizodzikisira kusevha, kurutsa, nezvimwe zvinetso zvemudumbu zvakanyanya. Kuderera kwekuwedzera kunorevawo kuti **vatambi vazhinji vakawana kuti zvibvutiro zvavo zvekutanga zvakaderera mukati memavhiki ekutanga 8 kusvika 12** ekusvika pamwero wakagadzikana.

Chii Chatisati Taziva?

Nekuti Retatrutide yakaongororwa chete kusvika mavhiki 68 mudzidzo dzayo dzakareba, data re kuchengetedza kwenguva refu kupfuura gore rimwe chete riri shoma. Hatisati taziva kuti maitiro ezvibvutiro anooneka sei pashure pezviviri, zvishanu, kana gumi remakore ekushandisa. Zvinetso nezve zvichibvira paumburumbwe, density ye pfupa, mass yemhasuru, uye hutano hwe thyroid zvinoramba zvakavhurika kusvikira dzidzo refu dzapiwa mhinduro.

Eli Lilly ane dzimwe nhatu dzeChikamu chechitatu dzichatarisirwa muna 2026, dzichifukidza kufutisa, chirwere cheshuga che Rudzi rwechipiri, kushaya kwehope, chirwere chiropa, kurwadziwa kusingaperi kwemusana, uye zvazvinoitika pamoyo. Idzi dzidzo dzichapa chifananidzo chakazara zvakanyanya che mabhenefiti ne njodzi.

Kana Retatrutide ikazombowana mvumo yeFDA, chiremba wako achakwanisa kukuongororera kuti maitiro ezvibvutiro anokodzera mamiriro ako here. Parizvino, data inoratidza mushonga une zvabuda zvekurasikirwa kwekurema zvine simba uye maitiro ezvibvutiro anogadzirisika kune vanhu vazhinji, kunyanya nekuderera kwezvinodiwa, kwakakodzera.